SSII
SS Innovations International, Inc.NASDAQHealthcare$5.00+3.09%ClosedMarket Cap: $971.8M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
24.86
P/S
22.88
EV/EBITDA
-154.11
DCF Value
$-16.69
FCF Yield
-2.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
45.3%
Operating Margin
-19.7%
Net Margin
-28.6%
ROE
-30.2%
ROA
-16.3%
ROIC
-17.2%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $14.5M | $-2.5M | $-0.01 |
| FY 2025 | $42.4M | $-12.1M | $-0.06 |
| Q3 2025 | $12.8M | $-3.7M | $-0.02 |
| Q2 2025 | $10.0M | $-256.7K | $-0.00 |
Trading Activity
Insider Trades
View AllCohen Barry Fdirector, officer: COO - Americas
SellFri Apr 03
Sudhir Srivastavadirector, 10 percent owner, officer: Chairman and CEO
SellWed Apr 01
Sudhir Srivastavadirector, 10 percent owner, officer: Chairman and CEO
SellFri Mar 27
MOLL FREDERIC Hdirector, 10 percent owner:
BuyTue Mar 10
Adams Timothy P.director
BuyTue Mar 10
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.91
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.